These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6461736)

  • 1. Use of moxalactam for bacterial meningitis.
    Kaplan SL; Mason EO; Feigin RD
    J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam in pediatrics.
    Barson WJ; Nahata MC
    Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
    [No Abstract]   [Full Text] [Related]  

  • 7. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of moxalactam].
    Acar JF
    Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Barriere SL; Wilson CB; Pons VG
    Neurosurgery; 1982 Jun; 10(6 Pt 1):762-5. PubMed ID: 6213879
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH; Schaad UB
    Rev Infect Dis; 1982; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract]   [Full Text] [Related]  

  • 11. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
    Nix WA; Hey O; Fabricius K
    Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
    Kumar A; Aziz MT
    Drug Intell Clin Pharm; 1981 Jan; 15(1):50-1. PubMed ID: 6456138
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs for enteric gram-negative bacillary meningitis in adults.
    Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of moxalactam into CSF.
    Landesman SH
    J Pediatr; 1982 Jul; 101(1):160-1. PubMed ID: 6211532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.